Navigation Links
Presentation at ISSN Highlights Soy Protein Advantages for Endurance Athletes

ST. LOUIS, Nov. 15 /PRNewswire/ -- Dr. Douglas Kalman of Miami Research Associates delivered good news for soy protein and its use for the endurance athlete at the International Society of Sports Nutrition (ISSN) conference on Nov. 10 in Ft. Lauderdale, Fla.

Kalman presented "Whey, Casein, Soy: Why Protein Sources are Different: Applications for Endurance Athletes," which highlighted several direct and comparative studies that examined just how, and if, these varied protein sources can be of benefit to the active adult.

Kalman said soy protein has at least two significant advantages that need to be known.

"While each protein source has its own benefits for metabolism, soy should be better recognized for its quick absorption rates, which means it can enhance muscle and exercise recovery, and its ability to have positive effects whether used in food or powder form," he said.

Kalman's recently peer-reviewed published study, "Effect of protein source and resistance training on body composition and sex hormones," examined the effects of soy and whey in healthy active weightlifting males over a 12-week period. The study found soy protein was just as effective as whey in its ability to help weightlifting males gain muscle. Additional findings noted soy did not have any negative effects on male hormonal levels. The study suggests soy and soy mixed with whey protein had positive effects on male sex hormones.

"Whether you are in a strict exercise regimen or just getting started, soy and other proteins deliver a great source of protein to build muscles," said Dr. Kathy Greaves, Solae Clinical Nutrition Group Lead. "The take home message of Dr. Kalman's presentation is clear: soy protein should be on the athlete's menu plan, and it is a safe, effective dietary protein that has many health-enhancing effects."

Dr. Jose Antonio, the ISSN Conference Chair, said athletes should strongly consider soy protein as a part of their diet.

"The Kalman study clearly delineated that the inclusion of soy protein as part of an athlete's nutritional plan is smart for more than just the obvious heart health reasons," Antonio said. "Now, we can state unequivocally that soy protein can have a strong, positive effect on muscle gains for the athlete when used almost daily and ingested after the workout. "To read the study, go to the Journal of the International Society of Sports Nutrition's Web site,

About Solae

Solae is the world leader in developing innovative soy-based technology to the food, meat and nutritional products industries. Solae provides solutions that deliver a unique combination of functional, nutritional and economic benefits to our customers. Headquartered in St. Louis, Missouri, USA, with annual revenue exceeding $1 billion, the company was formed through an alliance between Bunge Limited (NYSE: BG) and DuPont (NYSE: DD). For more information, visit

SOURCE The Solae Company
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
2. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
3. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
4. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
5. Haemonetics Webcast Presentation
6. Presentation at Bio Contact Quebec 2007
7. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
8. Accuray to Webcast Senior Management Presentations at Analyst Day Event
9. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
10. Exelixis Announces October 10 Webcast of Presentation at the 2007 Bio InvestorForum Conference
11. HMS Holdings Corp. Hosts Third Quarter 2007 Financial Teleconference and Presentation
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: